BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11306453)

  • 1. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
    Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW
    Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
    Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
    Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
    Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
    J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
    Chae KS; Ryu BK; Lee MG; Byun DS; Chi SG
    Eur J Cancer; 2002 Oct; 38(15):2048-57. PubMed ID: 12376211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
    Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A
    Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
    Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW
    Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
    Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.
    Robinson VL; Hickson JA; Vander Griend DJ; Dubauskas Z; Rinker-Schaeffer CW
    Clin Exp Metastasis; 2003; 20(1):25-30. PubMed ID: 12650604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.
    Su GH; Hilgers W; Shekher MC; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 1998 Jun; 58(11):2339-42. PubMed ID: 9622070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines.
    Meadows GG; Zhang H; Ge X
    J Nutr; 2001 Nov; 131(11 Suppl):3047S-50S. PubMed ID: 11694646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.
    Szmulewitz RZ; Clark R; Lotan T; Otto K; Taylor Veneris J; Macleod K; Rinker-Schaeffer C
    Int J Cancer; 2012 Feb; 130(3):509-20. PubMed ID: 21351092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
    Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
    Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
    Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
    Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
    Wang L; Pan Y; Dai JL
    Oncogene; 2004 Aug; 23(35):5978-85. PubMed ID: 15184866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mitogen-activated protein kinase kinase 4 in cancer.
    Whitmarsh AJ; Davis RJ
    Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
    Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
    Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells.
    Cazillis M; Bringuier AF; Delautier D; Buisine M; Bernuau D; Gespach C; Groyer A
    Oncogene; 2004 Jun; 23(27):4735-44. PubMed ID: 15122334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
    Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
    Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY
    Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.